Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodules.

Current opinion in endocrinology, diabetes, and obesity - 1 Oct 2007

Eszlinger Markus, Jaeschke Holger, Paschke Ralf

Abstract excerpt

PURPOSE OF REVIEW: To describe molecular pathways that might be of relevance for a potential pharmacologic therapy of benign thyroid nodules. RECENT FINDINGS: Constitutively activating thyrotropin receptor mutations have been found in about 60% of hot nodules. Its predominant role for signaling in hot nodules has been confirmed by in-vitro mutagenesis studies, thyrotropin receptor modeling and microarray studies....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Graves Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to GTP-Binding Protein alpha Subunits, Gq-G11

Share to Protein Kinase C

Share to Receptors, Thyrotropin

Share to Symporters

Share to Thyroglobulin

Share to Thyroid Nodule

Source

Identifiers

PMID: 17940470
DOI: 10.1097/MED.0b013e3282ef5f96

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodules.PMID 17940470Read ↗

[Pathophysiologic basis for prevention and pharmacotherapy of benign cold thyroid nodules].Semantic proximity Read ↗

Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approachesSemantic proximity Read ↗

The Role of the Kinase Inhibitors in Thyroid CancersSemantic proximity Read ↗

Thyroid nodules: pathophysiological insight on oncogenesis and novel diagnostic techniques.Semantic proximity Read ↗

This is Your Thyroid on Drugs: Targetable Mutations and Fusions in Thyroid Carcinoma.Semantic proximity Read ↗

This is Your Thyroid on Drugs: Targetable Mutations and Fusions in Thyroid Carcinoma.Semantic proximity Read ↗

Novel targeted therapies and immunotherapy for advanced thyroid cancers.Semantic proximity Read ↗

Expression of beta-arrestins in toxic and cold thyroid nodules.Semantic proximity Read ↗

[Thyroid carcinomas: the role of systemic therapies in internal medicine].Semantic proximity Read ↗

Differentiated thyroid cancers: a comprehensive review of novel targeted therapies.Semantic proximity Read ↗

Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases.Semantic proximity Read ↗

New mechanisms of radioiodide uptake revealed via a novel high throughput drug screening approach in thyroid cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.